Connect with us

Health

A pilot randomized controlled trial of ketamine in Borderline Personality Disorder

A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder

 


  • Masland SR, Price D, MacDonald J, Finch E, Gunderson J, Choi-Kain L. Enduring effects of one-day training in good psychiatric management on clinician attitudes about borderline personality disorder. J Nerv Ment Dis. 2018;206:865–9. https://doi.org/10.1097/NMD.0000000000000893

    Article 
    PubMed 

    Google Scholar
     

  • Comtois KA, Carmel A. Borderline personality disorder and high utilization of inpatient psychiatric hospitalization: concordance between research and clinical diagnosis. J Behav Health Serv Res. 2016;43:272–80. https://doi.org/10.1007/s11414-014-9416-9

    Article 
    PubMed 

    Google Scholar
     

  • Paris J. Suicidality in borderline personality disorder. Medicina. 2019;55:223 https://doi.org/10.3390/medicina55060223

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020;5:CD012955 https://doi.org/10.1002/14651858.CD012955.pub2

    Article 
    PubMed 

    Google Scholar
     

  • Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2006:CD005653. https://doi.org/10.1002/14651858.CD005653

  • McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for Ketamine and Esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178:383–99. https://doi.org/10.1176/appi.ajp.2020.20081251

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nandan NK, Soni PK, Parsaik A, Hashmi A. “Esketamine” in borderline personality disorder: a look beyond suicidality. Cureus. 2022;14:e24632 https://doi.org/10.7759/cureus.24632

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen KS, Dwivedi Y, Shelton RC. The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. J Affect Disord. 2022;315:13–16. https://doi.org/10.1016/j.jad.2022.07.054

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, et al. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry. 2012;72:964–70. https://doi.org/10.1016/j.biopsych.2012.05.028

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022;47:1574–81. https://doi.org/10.1038/s41386-022-01266-9

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psychiatry. 2021;178:193–202. https://doi.org/10.1176/appi.ajp.2020.20050596

    Article 
    PubMed 

    Google Scholar
     

  • Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013;38:2475–83. https://doi.org/10.1038/npp.2013.150

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44:1233–8. https://doi.org/10.1038/s41386-019-0317-8

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wilkowska A, Wiglusz MS, Jakuszkowiak-Wojten K, Cubala WJ. Ketamine and Lamotrigine combination in psychopharmacology: systematic review. Cells. 2022;11:645 https://doi.org/10.3390/cells11040645

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chiu CT, Scheuing L, Liu G, Liao HM, Linares GR, Lin D, et al. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int J Neuropsychopharmacol. 2014;18:pyu102 https://doi.org/10.1093/ijnp/pyu102

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Price JB, Yates CG, Morath BA, Van De Wakker SK, Yates NJ, Butters K, et al. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. Transl Psychiatry. 2021;11:598 https://doi.org/10.1038/s41398-021-01716-w

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Motaghinejad M, Motevalian M, Fatima S, Beiranvand T, Mozaffari S. Topiramate via NMDA, AMPA/kainate, GABA(A) and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats. J Neural Transm. 2017;124:1369–87. https://doi.org/10.1007/s00702-017-1771-2

    Article 
    PubMed 

    Google Scholar
     

  • First MB, Spitzer, RL, Gibbon, M, Williams, JBW Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition. In: Institute BRDNYSP, editor. New York, New York 2007.

  • Zanarini M, Frankenburg FR, Chauncey DL, Gunderson JG. The diagnostic interview for personality disorders: Interrater and test-retest reliability. Compr Psychiatry. 1987;28:467–580.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL. The revised diagnostic interview for borderlines: discriminating BPD from other axis II disorders. J Pers Disord. 1989;3:10–8.

    Article 

    Google Scholar
     

  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 4-57

    PubMed 

    Google Scholar
     

  • Overall JE The brief psychiatric rating scale in psychopharmacology research. 1974.

  • Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress. 1998;11:125–36. https://doi.org/10.1023/A:1024465317902

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consul Clin Psychol. 1979;47:343.

    Article 
    CAS 

    Google Scholar
     

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health. 2015;9:243–9. https://doi.org/10.1002/pmh.1302

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976;33:1111–5.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation;; 1996.


    Google Scholar
     

  • Beck AT, Brown GK, Steer RA. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther. 1997;35:1039–46. https://doi.org/10.1016/s0005-7967(97)00073-9

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003;17:233–42. https://doi.org/10.1521/pedi.17.3.233.22147

    Article 
    PubMed 

    Google Scholar
     

  • Mello RP, Echegaray MVF, Jesus-Nunes AP, Leal GC, Magnavita GM, Vieira F, et al. Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. J Psychiatr Res. 2021;138:576–83. https://doi.org/10.1016/j.jpsychires.2021.05.014

    Article 
    PubMed 

    Google Scholar
     

  • Perez S, Lorca F, Marco JH. “Dissociation, posttraumatic stress symptoms, emotional dysregulation, and invalidating environments as correlates of NSSI in borderline personality disorder patients”. J Trauma Dissociation. 2020;21:520–35. https://doi.org/10.1080/15299732.2020.1719262

    Article 
    PubMed 

    Google Scholar
     

  • Ebner-Priemer UW, Mauchnik J, Kleindienst N, Schmahl C, Peper M, Rosenthal MZ, et al. Emotional learning during dissociative states in borderline personality disorder. J Psychiatry Neurosci. 2009;34:214–22.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kleindienst N, Limberger MF, Ebner-Priemer UW, Keibel-Mauchnik J, Dyer A, Berger M, et al. Dissociation predicts poor response to Dialectial Behavioral Therapy in female patients with Borderline Personality Disorder. J Pers Disord. 2011;25:432–47. https://doi.org/10.1521/pedi.2011.25.4.432

    Article 
    PubMed 

    Google Scholar
     

  • Kleindienst N, Priebe K, Gorg N, Dyer A, Steil R, Lyssenko L, et al. State dissociation moderates response to dialectical behavior therapy for posttraumatic stress disorder in women with and without borderline personality disorder. Eur J Psychotraumatol. 2016;7:30375 https://doi.org/10.3402/ejpt.v7.30375

    Article 
    PubMed 

    Google Scholar
     

  • Arntz A, Stupar-Rutenfrans S, Bloo J, van Dyck R, Spinhoven P. Prediction of treatment discontinuation and recovery from Borderline Personality Disorder: Results from an RCT comparing Schema Therapy and Transference Focused Psychotherapy. Behav Res Ther. 2015;74:60–71. https://doi.org/10.1016/j.brat.2015.09.002

    Article 
    PubMed 

    Google Scholar
     

  • Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Prim. 2018;4:18029 https://doi.org/10.1038/nrdp.2018.29

    Article 
    PubMed 

    Google Scholar
     

  • Stoffers-Winterling J, Storebo OJ, Lieb K. Pharmacotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies. Curr Psychiatry Rep. 2020;22:37 https://doi.org/10.1007/s11920-020-01164-1

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71:681–8. https://doi.org/10.1001/jamapsychiatry.2014.62

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rizk MM, Choo TH, Galfalvy H, Biggs E, Brodsky BS, Oquendo MA, et al. Variability in suicidal ideation is associated with affective instability in suicide attempters with borderline personality disorder. Psychiatry. 2019;82:173–8. https://doi.org/10.1080/00332747.2019.1600219

    Article 
    PubMed 

    Google Scholar
     

  • Links PS, Eynan R, Heisel MJ, Barr A, Korzekwa M, McMain S, et al. Affective instability and suicidal ideation and behavior in patients with borderline personality disorder. J Pers Disord. 2007;21:72–86. https://doi.org/10.1521/pedi.2007.21.1.72

    Article 
    PubMed 

    Google Scholar
     

  • Kleiman EM, Turner BJ, Fedor S, Beale EE, Picard RW, Huffman JC, et al. Digital phenotyping of suicidal thoughts. Depress Anxiety. 2018;35:601–8. https://doi.org/10.1002/da.22730

    Article 
    PubMed 

    Google Scholar
     

  • Bloomfield-Clagett B, Ballard ED, Greenstein DK, Wilkinson ST, Grunebaum MF, Murrough JW, et al. A participant-level integrative data analysis of differential placebo response for suicidal ideation and non-suicidal depressive symptoms in clinical trials of intravenous Racemic Ketamine. Int J Neuropsychopharmacol. 2022;25:827–38. https://doi.org/10.1093/ijnp/pyac055

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gunderson JG, Choi-Kain LW. Medication management for patients with borderline personality disorder. Am J Psychiatry. 2018;175:709–11. https://doi.org/10.1176/appi.ajp.2018.18050576

    Article 
    PubMed 

    Google Scholar
     

  • Fineberg SK, Gupta S, Leavitt J. Collaborative deprescribing in borderline personality disorder: a narrative review. Harv Rev Psychiatry. 2019;27:75–86. https://doi.org/10.1097/HRP.0000000000000200

    Article 
    PubMed 

    Google Scholar
     

  • Neustadter ES, Fineberg SK, Leavitt J, Carr MM, Corlett PR. Induced illusory body ownership in borderline personality disorder. Neurosci Conscious. 2019;2019:niz017 https://doi.org/10.1093/nc/niz017

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–4. https://doi.org/10.1016/s0006-3223(99)00230-9

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wlodarczyk A, Cubala WJ, Galuszko-Wegielnik M, Szarmach J. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study. Medicine. 2021;100:e26769 https://doi.org/10.1097/MD.0000000000026769

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2012;169:476–83. https://doi.org/10.1176/appi.ajp.2011.11101550

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years. Psychiatry Res. 2018;262:40–5. https://doi.org/10.1016/j.psychres.2018.01.034

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dean RL, Hurducas C, Hawton K, Spyridi S, Cowen PJ, Hollingsworth S, et al. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Cochrane Database Syst Rev. 2021;9:CD011612 https://doi.org/10.1002/14651858.CD011612.pub3

    Article 
    PubMed 

    Google Scholar
     

  • Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, et al. Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry. 2019;176:401–9. https://doi.org/10.1176/appi.ajp.2018.18070834

    Article 
    PubMed 

    Google Scholar
     

  • Sources

    1/ https://Google.com/

    2/ https://www.nature.com/articles/s41386-023-01540-4

    The mention sources can contact us to remove/changing this article

    What Are The Main Benefits Of Comparing Car Insurance Quotes Online

    LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

    ExBUlletin

    to request, modification Contact us at Here or [email protected]